Author:
Valenzuela M,Glorieux C,Stockis J,Sid B,Sandoval J M,Felipe K B,Kviecinski M R,Verrax J,Calderon P Buc
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Ablain J, Leiva M, Peres L, Fonsart J, Anthony E, de The H (2013) Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies. J Exp Med 210: 647–653.
2. Alarifi S, Ali D, Alkahtani S, Siddiqui MA, Ali BA (2013) Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells. Onco Targets Ther 6: 75–84.
3. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W, Klaus M (1992) A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 89: 7129–7133.
4. Chen Y, Lin-Shiau S, JK LIN (1998) Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 177: 324–333.
5. Chendamarai E, Balasubramanian P, George B, Viswabandya A, Abraham A, Ahmed R, Alex AA, Ganesan S, Lakshmi KM, Sitaram U, Nair SC, Chandy M, Janet NB, Srivastava VM, Srivastava A, Mathews V (2012) Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy. Blood 119: 3413–3419.
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献